Dudediligence.

CDT Equity Inc

CDTNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

631K

on 2026-06-30, from 80 on 2025-06-30 10-Q ↗

Earlier counts are adjusted for three reverse splits; each bar's tip shows the count as filed.

Counts before 2025-06-30 are left out: the count went from 317 on 2025-03-31 to 80 on 2025-06-30, a change no split on file explains.

200K400K600K1:120 split1:25 split1:10 splitJun2025SepDecMar2026Jun

Newest

S-3 of 2025-07-31. Not read yet. S-3 ↗

$25.0M

Agreement of 2026-01-16. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

None

Priced warrants: none left. Adjusted for three reverse splits. 10-Q ↗

Cash

0.3 quarters

$747K on 2026-06-30 ÷ $2.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 37 of its filings are not read yet.

Also on file: a 1-for-25 reverse split, 2026-03-26 8-K ↗ · a 1-for-10 reverse split, 2026-07-17 8-K ↗ · a 1-for-25 reverse split, 2026-09-28 8-K ↗